PharmaNutra
€70.20Change from previous close: −1.40%Absolute change: −€1.00
At a glance
- Revenue growth
- +13.83%
- 2025 vs 2024
- Net income growth
- +20.44%
- 2025 vs 2024
- Net margin
- 15.0%
- 2024: 14.2%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 125 | 117 | 112 | 100 | — |
| Current assets | 72.9 | 65.0 | 58.7 | 58.7 | — |
| Cash and equivalents | 18.6 | 15.5 | 18.9 | 22.1 | — |
| Short-term investments | 12.0 | 13.5 | 6.2 | 4.8 | — |
| Inventory | 8.9 | 6.9 | 8.2 | 5.3 | — |
| Net property, plant and equipment | 24.1 | 25.7 | 26.4 | 17.1 | — |
| Goodwill | 17.6 | 17.6 | 17.6 | 17.6 | — |
| Other intangible assets | 6.9 | 5.7 | 5.0 | 4.0 | — |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Current liabilities | 31.0 | 27.3 | 27.6 | 25.8 | — |
| Accounts payable | 19.9 | 15.8 | 16.1 | 16.9 | — |
| Long-term debt | 14.4 | 18.1 | 22.2 | 13.6 | — |
| Total debt | 20.5 | 24.3 | 28.0 | 17.7 | — |
| Total liabilities | 54.0 | 55.3 | 58.0 | 49.2 | — |
| Total equity (incl. minority) | 71.2 | 62.1 | 54.4 | 50.9 | — |
| Retained earnings | 20.0 | 16.6 | 12.8 | 15.0 | — |
| Minority interest | -0.1 | -0.0 | 0.0 | — | — |